Propionic Acid

Propionic Acid

SCHEMBL6697023

CCC(=O)O.O=C1C=COC1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.40
NLRP3 Q96P20 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5024764 0.73 NLRP3 (0.32) NLRP3
Propionic Acid SCHEMBL29774514 0.71
Benzoquinone SCHEMBL3738782 0.68 FFAR3 (0.59) FFAR3
Benzene SCHEMBL4141661 0.67 FFAR3 (0.50) FFAR3
Propionic Acid SCHEMBL5668492 0.66
Propionic Acid SCHEMBL6846501 0.66
Cyclopentane SCHEMBL97373 0.64 FFAR3 (0.83) FFAR3
Cyclohexane SCHEMBL2585876 0.64 FFAR3 (0.83) FFAR3
Benzene SCHEMBL21273380 0.64 FFAR3 (0.83) FFAR3
Propionic Acid SCHEMBL5062880 0.64 FFAR3 (0.83) FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082643-A1 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus WYETH (US) 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082643-A1 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus HAVCR2, HCCS, ZC3HAV1 FFAR3 2121/4885NLRP3 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.